tiprankstipranks
Advertisement
Advertisement

DE:41O Stock Latest News

Outlook Therapeutics Resubmits FDA Application for ONS-5010
Company AnnouncementsOutlook Therapeutics Resubmits FDA Application for ONS-5010
5d ago
8K
OTLK
Outlook Therapeutics resubmits biologics license application to FDA
PremiumThe Fly
Outlook Therapeutics resubmits biologics license application to FDA
5d ago
OTLK
Outlook Therapeutics Announces Registered Direct Equity Offering
PremiumCompany Announcements
Outlook Therapeutics Announces Registered Direct Equity Offering
8d ago
8K
OTLK
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
8d ago
NFE
YSS
Outlook Therapeutics Announces Insider-Backed Direct Stock Offering
PremiumCompany Announcements
Outlook Therapeutics Announces Insider-Backed Direct Stock Offering
9d ago
8K
OTLK
Outlook Therapeutics announces pricing of $5M registered direct offering
PremiumThe FlyOutlook Therapeutics announces pricing of $5M registered direct offering
9d ago
OTLK
Outlook to sell 8.54M shares at 58.55c in registered direct offering
Premium
The Fly
Outlook to sell 8.54M shares at 58.55c in registered direct offering
9d ago
OTLK
Outlook Therapeutics wins appeal following FDR process for ONS-5010/Lytenava
Premium
The Fly
Outlook Therapeutics wins appeal following FDR process for ONS-5010/Lytenava
12d ago
OTLK
Outlook Therapeutics Wins FDA Appeal for LYTENAVA Resubmission
PremiumCompany Announcements
Outlook Therapeutics Wins FDA Appeal for LYTENAVA Resubmission
12d ago
8K
OTLK
Outlook Therapeutics downgraded to Neutral from Buy at BTIG
PremiumThe Fly
Outlook Therapeutics downgraded to Neutral from Buy at BTIG
20d ago
OTLK
Outlook Therapeutics reports Q2 adjusted EPS (16c), consensus (12c)
PremiumThe Fly
Outlook Therapeutics reports Q2 adjusted EPS (16c), consensus (12c)
22d ago
OTLK
Outlook Therapeutics Launches New $100M ATM Offering
PremiumCompany Announcements
Outlook Therapeutics Launches New $100M ATM Offering
24d ago
8K
OTLK
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsOTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
26d ago
OTLK
Outlook Therapeutics Announces New Equity Financing Transaction
Premium
Company Announcements
Outlook Therapeutics Announces New Equity Financing Transaction
1M ago
8K
OTLK
Outlook Therapeutics to sell 16.129M shares at 31c in registered direct offering
Premium
The Fly
Outlook Therapeutics to sell 16.129M shares at 31c in registered direct offering
2M ago
OTLK
Outlook Therapeutics Advances FDA Dispute on Wet AMD Drug
PremiumCompany Announcements
Outlook Therapeutics Advances FDA Dispute on Wet AMD Drug
2M ago
8K
OTLK
Outlook Therapeutics completes Federal Dispute Resolution meeting with FDA
PremiumThe Fly
Outlook Therapeutics completes Federal Dispute Resolution meeting with FDA
2M ago
OTLK
Regulatory Uncertainty and Data Limitations Justify Hold Rating and Constrained Upside for Outlook Therapeutics
PremiumRatings
Regulatory Uncertainty and Data Limitations Justify Hold Rating and Constrained Upside for Outlook Therapeutics
2M ago
OTLK
Outlook Therapeutics Pursues FDA Dispute Resolution for ONS-5010
PremiumCompany Announcements
Outlook Therapeutics Pursues FDA Dispute Resolution for ONS-5010
2M ago
8K
OTLK
Outlook Therapeutics submits formal dispute resolution request to FDA
PremiumThe FlyOutlook Therapeutics submits formal dispute resolution request to FDA
2M ago
OTLK
Outlook Therapeutics Completes Dilutive Equity Offering With Warrants
Premium
Company Announcements
Outlook Therapeutics Completes Dilutive Equity Offering With Warrants
2M ago
8K
OTLK
Outlook Therapeutics announces common stock, warrant offering, no amount given
Premium
The Fly
Outlook Therapeutics announces common stock, warrant offering, no amount given
3M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >